Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis

Pat Fidler, Charles Lawrence Loprinzi, Judith R. O'Fallon, John M. Leitch, Jeraldine K. Lee, Debra L. Hayes, Paul Novotny, Danette Clemens-Schutjer, Joan Bartel, John C. Michalak

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

BACKGROUND. Stomatitis has been found to be a major dose-limiting toxicity from bolus 5-fluorouracil-based (5-FU) chemotherapy regimens, despite the use of oral cryotherapy. Pursuant to preliminary data which suggested that a chamomile mouthwash might ameliorate this toxicity, a prospective trial was developed to test chamomile in this situation. METHODS. A Phase III, double-blind, placebo-controlled clinical trial was designed. Patients were entered into the study at the time of their first cycle of 5-FU-based chemotherapy. All patients received oral cryotherapy for 30 minutes with each dose of 5-FU. In addition, each patient was randomized to receive a chamomile or placebo mouthwash thrice daily for 14 days. Stomatitis scores were determined by health care providers and by patients themselves. RESULTS. There were 164 evaluable and well-stratified patients equally randomized to both treatment groups. There was no suggestion of any stomatitis difference between patients randomized to either protocol arm. There was also no suggestion of toxicity. Subset analysis did reveal unsuspected differential effects between males and females that could not be explained by reasons other than chance. CONCLUSION. The resultant data from this clinical trial did not support the prestudy hypothesis that chamomile could decrease 5-FU-induced stomatitis.

Original languageEnglish (US)
Pages (from-to)522-525
Number of pages4
JournalCancer
Volume77
Issue number3
StatePublished - Feb 1 1996

Fingerprint

Chamomile
Mouthwashes
Stomatitis
Fluorouracil
Cryotherapy
Placebos
Drug Therapy
Controlled Clinical Trials
Health Personnel
Clinical Trials

Keywords

  • Chamomile
  • Chemotherapy toxicity
  • Mucositis
  • Stomatitis
  • Symptom-control study

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fidler, P., Loprinzi, C. L., O'Fallon, J. R., Leitch, J. M., Lee, J. K., Hayes, D. L., ... Michalak, J. C. (1996). Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer, 77(3), 522-525.

Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. / Fidler, Pat; Loprinzi, Charles Lawrence; O'Fallon, Judith R.; Leitch, John M.; Lee, Jeraldine K.; Hayes, Debra L.; Novotny, Paul; Clemens-Schutjer, Danette; Bartel, Joan; Michalak, John C.

In: Cancer, Vol. 77, No. 3, 01.02.1996, p. 522-525.

Research output: Contribution to journalArticle

Fidler, P, Loprinzi, CL, O'Fallon, JR, Leitch, JM, Lee, JK, Hayes, DL, Novotny, P, Clemens-Schutjer, D, Bartel, J & Michalak, JC 1996, 'Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis', Cancer, vol. 77, no. 3, pp. 522-525.
Fidler P, Loprinzi CL, O'Fallon JR, Leitch JM, Lee JK, Hayes DL et al. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer. 1996 Feb 1;77(3):522-525.
Fidler, Pat ; Loprinzi, Charles Lawrence ; O'Fallon, Judith R. ; Leitch, John M. ; Lee, Jeraldine K. ; Hayes, Debra L. ; Novotny, Paul ; Clemens-Schutjer, Danette ; Bartel, Joan ; Michalak, John C. / Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. In: Cancer. 1996 ; Vol. 77, No. 3. pp. 522-525.
@article{0bc8b5f1c1d9429b80acbf38b0a1b628,
title = "Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis",
abstract = "BACKGROUND. Stomatitis has been found to be a major dose-limiting toxicity from bolus 5-fluorouracil-based (5-FU) chemotherapy regimens, despite the use of oral cryotherapy. Pursuant to preliminary data which suggested that a chamomile mouthwash might ameliorate this toxicity, a prospective trial was developed to test chamomile in this situation. METHODS. A Phase III, double-blind, placebo-controlled clinical trial was designed. Patients were entered into the study at the time of their first cycle of 5-FU-based chemotherapy. All patients received oral cryotherapy for 30 minutes with each dose of 5-FU. In addition, each patient was randomized to receive a chamomile or placebo mouthwash thrice daily for 14 days. Stomatitis scores were determined by health care providers and by patients themselves. RESULTS. There were 164 evaluable and well-stratified patients equally randomized to both treatment groups. There was no suggestion of any stomatitis difference between patients randomized to either protocol arm. There was also no suggestion of toxicity. Subset analysis did reveal unsuspected differential effects between males and females that could not be explained by reasons other than chance. CONCLUSION. The resultant data from this clinical trial did not support the prestudy hypothesis that chamomile could decrease 5-FU-induced stomatitis.",
keywords = "Chamomile, Chemotherapy toxicity, Mucositis, Stomatitis, Symptom-control study",
author = "Pat Fidler and Loprinzi, {Charles Lawrence} and O'Fallon, {Judith R.} and Leitch, {John M.} and Lee, {Jeraldine K.} and Hayes, {Debra L.} and Paul Novotny and Danette Clemens-Schutjer and Joan Bartel and Michalak, {John C.}",
year = "1996",
month = "2",
day = "1",
language = "English (US)",
volume = "77",
pages = "522--525",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis

AU - Fidler, Pat

AU - Loprinzi, Charles Lawrence

AU - O'Fallon, Judith R.

AU - Leitch, John M.

AU - Lee, Jeraldine K.

AU - Hayes, Debra L.

AU - Novotny, Paul

AU - Clemens-Schutjer, Danette

AU - Bartel, Joan

AU - Michalak, John C.

PY - 1996/2/1

Y1 - 1996/2/1

N2 - BACKGROUND. Stomatitis has been found to be a major dose-limiting toxicity from bolus 5-fluorouracil-based (5-FU) chemotherapy regimens, despite the use of oral cryotherapy. Pursuant to preliminary data which suggested that a chamomile mouthwash might ameliorate this toxicity, a prospective trial was developed to test chamomile in this situation. METHODS. A Phase III, double-blind, placebo-controlled clinical trial was designed. Patients were entered into the study at the time of their first cycle of 5-FU-based chemotherapy. All patients received oral cryotherapy for 30 minutes with each dose of 5-FU. In addition, each patient was randomized to receive a chamomile or placebo mouthwash thrice daily for 14 days. Stomatitis scores were determined by health care providers and by patients themselves. RESULTS. There were 164 evaluable and well-stratified patients equally randomized to both treatment groups. There was no suggestion of any stomatitis difference between patients randomized to either protocol arm. There was also no suggestion of toxicity. Subset analysis did reveal unsuspected differential effects between males and females that could not be explained by reasons other than chance. CONCLUSION. The resultant data from this clinical trial did not support the prestudy hypothesis that chamomile could decrease 5-FU-induced stomatitis.

AB - BACKGROUND. Stomatitis has been found to be a major dose-limiting toxicity from bolus 5-fluorouracil-based (5-FU) chemotherapy regimens, despite the use of oral cryotherapy. Pursuant to preliminary data which suggested that a chamomile mouthwash might ameliorate this toxicity, a prospective trial was developed to test chamomile in this situation. METHODS. A Phase III, double-blind, placebo-controlled clinical trial was designed. Patients were entered into the study at the time of their first cycle of 5-FU-based chemotherapy. All patients received oral cryotherapy for 30 minutes with each dose of 5-FU. In addition, each patient was randomized to receive a chamomile or placebo mouthwash thrice daily for 14 days. Stomatitis scores were determined by health care providers and by patients themselves. RESULTS. There were 164 evaluable and well-stratified patients equally randomized to both treatment groups. There was no suggestion of any stomatitis difference between patients randomized to either protocol arm. There was also no suggestion of toxicity. Subset analysis did reveal unsuspected differential effects between males and females that could not be explained by reasons other than chance. CONCLUSION. The resultant data from this clinical trial did not support the prestudy hypothesis that chamomile could decrease 5-FU-induced stomatitis.

KW - Chamomile

KW - Chemotherapy toxicity

KW - Mucositis

KW - Stomatitis

KW - Symptom-control study

UR - http://www.scopus.com/inward/record.url?scp=0030058169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030058169&partnerID=8YFLogxK

M3 - Article

C2 - 8630960

AN - SCOPUS:0030058169

VL - 77

SP - 522

EP - 525

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -